BOSTON -- Consolidated Stills and Sterilizers announced that it has received approval from the Food and Drug Administration (FDA) to market its MARK V microprocessor-controlled steam sterilizers. This approval allows Consolidated to expand its current product offering to the healthcare market. The company will provide an array of sizes and features suitable for operating rooms and central sterile supply.
Consolidated Stills and Sterilizers has produced sterilizers for the global Biotech and Medical-Research markets since 1946.
Robust infectious disease surveillance, including rapid subtyping of influenza A, is essential for early detection, containment, and public health reporting of novel viral threats.